Ambalal Sarabhai Enterprises has received approval to enter into Share Purchase Agreement (SPA) with Asence Pharma for sale of 120446 (35,000 equity shares of face value of Rs 1000 each Rs 100 paid up, and 85,446 equity shares of face value of Rs 1000 each Rs 1000 paid up aggregating 120,446 equity shares) equity shares of Synbiotics, a wholly owned subsidiary to Asence Pharma, another subsidiary of the Company on consideration of Rs 11,91,87,640.
Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1870.50 |
| Dr. Reddys Labs. | 1330.90 |
| Cipla | 1432.65 |
| Zydus Lifesciences | 1104.50 |
| Lupin | 2369.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: